TY - JOUR
T1 - Haptoglobin therapy for acute favism
T2 - A Japanese boy with glucose-6-phosphate dehydrogenase Guadalajara
AU - Ohga, S.
AU - Higashi, E.
AU - Nomura, A.
AU - Matsuzaki, A.
AU - Hirono, A.
AU - Miwa, S.
AU - Fujii, H.
AU - Ueda, K.
PY - 1995
Y1 - 1995
N2 - We report the case of a 2-year-old Japanese boy with acute favism who was treated with human haptoglobin products. He had been exhibiting chronic nonspherocytic haemolytic anaemia until the diagnosis of glucose-6-phosphate dehydrogenase (G6PD) deficiency when 14 months old. He suffered a favic crisis at 24 months of age, when the administration of haptoglobin was effective for relieving bilirubinaemia and haemoglobinuria. Serum-free Hb rapidly decreased to normal levels despite the sustained level of serum lactate dehydrogenase. His G6PD gene was G6PD Guadalajara. This is the first application of haptoglobin therapy for acute favism and the first reported case of Japanese G6PD deficiency with typical favic crisis. Haptoglobin treatment might be helpful for managing the haemolytic crisis in the disease.
AB - We report the case of a 2-year-old Japanese boy with acute favism who was treated with human haptoglobin products. He had been exhibiting chronic nonspherocytic haemolytic anaemia until the diagnosis of glucose-6-phosphate dehydrogenase (G6PD) deficiency when 14 months old. He suffered a favic crisis at 24 months of age, when the administration of haptoglobin was effective for relieving bilirubinaemia and haemoglobinuria. Serum-free Hb rapidly decreased to normal levels despite the sustained level of serum lactate dehydrogenase. His G6PD gene was G6PD Guadalajara. This is the first application of haptoglobin therapy for acute favism and the first reported case of Japanese G6PD deficiency with typical favic crisis. Haptoglobin treatment might be helpful for managing the haemolytic crisis in the disease.
UR - http://www.scopus.com/inward/record.url?scp=0028962122&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028962122&partnerID=8YFLogxK
U2 - 10.1111/j.1365-2141.1995.tb03322.x
DO - 10.1111/j.1365-2141.1995.tb03322.x
M3 - Article
C2 - 7873396
AN - SCOPUS:0028962122
SN - 0007-1048
VL - 89
SP - 421
EP - 423
JO - British Journal of Haematology
JF - British Journal of Haematology
IS - 2
ER -